Jazz Pharmaceuticals (JAZZ) executive compensation, 2026 proxy

Renee D. Gala, President, CEO and Director, was paid $19.2M in 2025, up 189% from $6.6M the year before. The CEO-to-median-employee pay ratio was 69:1, on median employee pay of $281,424.

Filed
June 8, 2026
Annual meeting
July 23, 2026
Pay year
2025
Named executives
6
CEO total pay
$19.2M+189% vs prior year
CEO to median employee
69:1median $281,424
CEO pay in equity
84%$16.1M in awards
Annual bonus achievement
150%Of target
PSU cycle payout
94%2023–2025 performance period
Gala target bonus
110%Of base salary
Other NEO target bonus
65%Of base salary
Annualized CEO compensation
$19,348,329Used for pay ratio

How Gala was paid

$19.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary5%Stock awards84%Non-equity incentive10%All other compensation0%

Named executive officers

ExecutiveTotal
Renee D. GalaPresident, CEO and Director$19,151,558
Philip L. JohnsonExecutive Vice President and CFO$7,544,473
Bruce C. CozaddChairperson and former CEO$18,834,836
Robert Iannone, M.D., M.S.C.EExecutive Vice President, Global Head of R&D$8,661,758
Neena M. PatilExecutive Vice President and Chief Legal Officer$6,299,539
Samantha PearceExecutive Vice President, Chief Commercial Officer$6,076,127

What changed and why

  • $19.2M$19,151,558: Gala’s 2025 total compensation exceeded her 2024 total of $6,628,888 after becoming CEO in August.
  • $16.1M$16,138,433: Gala’s stock awards included promotion-related equity following the CEO transition.
  • 150%150% of target: 2025 annual bonus performance reflected achievement against corporate objectives.
  • 94%94% of target: The 2023–2025 PSU cycle payout followed a 97% preliminary payout reduced by relative TSR.
  • $12M$12,041,389: Cozadd’s option modification expense reflected amended outstanding awards during his transition and retirement.
  • $281K69:1: Gala’s annualized CEO compensation compared with median employee compensation of $281,424.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.